![]() |
|
|
SM Sadrzadeh, AA Nanji and PL Price
Department of Pathology, New England Deaconess Hospital, Boston, MA 02215.
The effect of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) on liver nonheme iron, lipid peroxidation and hepatic fat accumulation in the intragastric feeding rat model for alcoholic liver disease was studied. Male Wistar rats (225-250 g) were fed liquid diet and ethanol for 1 month. In control pair-fed animals, ethanol was replaced isocalorically by dextrose. Two additional groups of animals (dextrose and ethanol-fed) received L1 (75 mg/kg/day for 30 days). The blood ethanol level in the ethanol-fed animals was maintained between 150 and 350 mg/dl. For each animal, the levels of hepatic nonheme iron, lipid peroxidation and triglyceride were evaluated. The nonheme iron in alcohol-fed animals was significantly higher (416 +/- 15 nmol/g of liver) than in pair-fed dextrose controls (346 +/- 18.5 nmol/g, P < .05). Animals fed ethanol and L1 had significantly lower nonheme iron (364 +/- 9.3 nmol/g) than rats fed ethanol alone (P < .05). L1 had no effect on nonheme iron levels in dextrose-fed controls. The importance of iron in lipid peroxidation in this model is shown by the positive correlation between the nonheme iron levels and microsomal conjugated dienes (r = 0.67, P < .02) and liver thiobarbituric acid reactive substances (r = 0.62, P < .05). The most significant observations in this study were: 1) the higher hepatic nonheme iron content in ethanol- fed rats compared to pair-fed dextrose controls; 2) lower nonheme iron and liver fat in the ethanol-fed rats treated with L1; and 3) the significant positive correlation between the liver nonheme and lipid peroxidation.
This article has been cited by other articles:
![]() |
S. Xiong, H. She, A.-S. Zhang, J. Wang, H. Mkrtchyan, A. Dynnyk, V. R. Gordeuk, S. W. French, C. A. Enns, and H. Tsukamoto Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G512 - G521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bai and A. I. Cederbaum Overexpression of CYP2E1 in Mitochondria Sensitizes HepG2 Cells to the Toxicity Caused by Depletion of Glutathione J. Biol. Chem., February 24, 2006; 281(8): 5128 - 5136. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. She, S. Xiong, M. Lin, E. Zandi, C. Giulivi, and H. Tsukamoto Iron activates NF-kappa B in Kupffer cells Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G719 - G726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Nanji, K. Jokelainen, M. Fotouhinia, A. Rahemtulla, P. Thomas, G. L. Tipoe, G. L. Su, and A. J. Dannenberg Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1348 - G1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Caro and A. I. Cederbaum Synergistic Toxicity of Iron and Arachidonic Acid in HepG2 Cells Overexpressing CYP2E1 Mol. Pharmacol., October 1, 2001; 60(4): 742 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. H. Sadrzadeh and A. A. Nanji The 21-Aminosteroid 16-Desmethyl Tirilazad Mesylate Prevents Necroinflammatory Changes in Experimental Alcoholic Liver Disease J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 406 - 412. [Abstract] [Full Text] |
||||
![]() |
S. M. H. Sadrzadeh, P. E. Hallaway, and A. A. Nanji The Long-Acting Parenteral Iron Chelator, Hydroxyethyl Starch-Deferoxamine, Fails to Protect against Alcohol-Induced Liver Injury in Rats J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1038 - 1042. [Abstract] [Full Text] |
||||
![]() |
D. Wu and A. I. Cederbaum Ethanol Cytotoxicity to a Transfected HepG2 Cell Line Expressing Human Cytochrome P4502E1 J. Biol. Chem., September 27, 1996; 271(39): 23914 - 23919. [Abstract] [Full Text] [PDF] |
||||